Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
J Pediatr. 2020 Jun;221:39-46.e5. doi: 10.1016/j.jpeds.2020.02.038.
To evaluate the hypothesis that early-onset sepsis increases risk of death or neurodevelopmental impairment (NDI) among preterm infants; and that among infants without early-onset sepsis, prolonged early antibiotics alters risk of death/NDI.
Retrospective cohort study of infants born at the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network centers (2006-2014) at 22-26 weeks of gestation and birth weight 401-1000 g. Early-onset sepsis defined as growth of a pathogen from blood or cerebrospinal fluid culture ≤72 hours after birth. Prolonged early antibiotics was defined as antibiotics initiated ≤72 hours and continued ≥5 days without culture-confirmed infection, necrotizing enterocolitis, or spontaneous perforation. Primary outcome was death before follow-up or NDI assessed at 18-26 months corrected age. Poisson regression was used to estimate adjusted relative risk (aRR) and CI for early-onset sepsis outcomes. A propensity score for receiving prolonged antibiotics was derived from early clinical factors and used to match infants (1:1) with and without prolonged antibiotic exposure. Log binomial models were used to estimate aRR for outcomes in matched infants.
Among 6565 infants, those with early-onset sepsis had higher aRR (95% CI) for death/NDI compared with infants managed with prolonged antibiotics (1.18 [1.06-1.32]) and to infants without prolonged antibiotics (1.23 [1.10-1.37]). Propensity score matching was achieved for 4362 infants. No significant difference in death/NDI (1.04 [0.98-1.11]) was observed with or without prolonged antibiotics among the matched cohort.
Early-onset sepsis was associated with increased risk of death/NDI among extremely preterm infants. Among matched infants without culture-confirmed infection, prolonged early antibiotic administration was not associated with death/NDI.
评估早发性败血症增加极早产儿死亡或神经发育障碍(NDI)风险的假设;以及在没有早发性败血症的婴儿中,早期抗生素延长是否改变死亡/ NDI 的风险。
对 Eunice Kennedy Shriver 国家儿童健康与人类发展研究所新生儿研究网络中心(2006-2014 年)出生的 22-26 周胎龄和体重 401-1000 克的婴儿进行回顾性队列研究。早发性败血症定义为出生后 72 小时内从血液或脑脊液培养物中生长出病原体。早期抗生素延长定义为起始抗生素≤72 小时,并在无培养证实的感染、坏死性小肠结肠炎或自发性穿孔的情况下继续使用≥5 天。主要结局是在随访前死亡或在 18-26 个月校正年龄时评估的 NDI。泊松回归用于估计早发性败血症结局的调整相对风险(aRR)和置信区间(CI)。通过早期临床因素得出接受延长抗生素治疗的倾向评分,并将其与接受和不接受延长抗生素暴露的婴儿(1:1)进行匹配。使用对数二项式模型估计匹配婴儿的结局的 aRR。
在 6565 名婴儿中,与接受延长抗生素治疗的婴儿(1.18 [1.06-1.32])和未接受延长抗生素治疗的婴儿(1.23 [1.10-1.37])相比,患有早发性败血症的婴儿死亡/NDI 的 aRR(95%CI)更高。对 4362 名婴儿进行了倾向评分匹配。在匹配队列中,有无延长抗生素治疗的婴儿在死亡/NDI 方面没有显著差异(1.04 [0.98-1.11])。
早发性败血症与极早产儿死亡/NDI 风险增加相关。在无培养证实感染的匹配婴儿中,早期抗生素延长给药与死亡/NDI 无关。